Article Sidebar

PDF
Date Published: 28/02/2023
Online Published: 03/03/2023
Abstract Views: 320
Views PDF: 134
DOI: https://doi.org/10.55046/vjrnm.50.705.2023
Issue
No. 50 (2023)
Section
Scientific research
How to Cite
Nguyen, Y., Le, V. K., Nguyen, T. T. T., Nguyen, T. K., Doan, T. K. O., & Vu, D. L. (2023). THE INITIAL RESULTS OF INTRAOPERATIVE RADIOFREQUENCY ABLATION IN TREATING HEPATOCELLULAR CARCINOMA . Vietnamese Journal of Radiology and Nuclear Medicine, 50, 14-22. https://doi.org/10.55046/vjrnm.50.705.2023

THE INITIAL RESULTS OF INTRAOPERATIVE RADIOFREQUENCY ABLATION IN TREATING HEPATOCELLULAR CARCINOMA

Yen Nguyen1,, Le Van Khang2, Nguyen Thị Thu Thao3, Nguyen Thi Khoi3, Doan Thi Kieu Oanh3, Vu Dang Luu2
1 Bệnh viện Bạch Mai
2 Department of Diagnostic Imaging – Hanoi Medical University
3 Radiology Center - Bach Mai Hospital

Main Article Content

Abstract

Intraoperative radiofrequency ablation is a new approach for the radical treatment of patients with multifocal hepatocellular carcinoma in different lobes. Originally, patients no longer indicated for radical treatment were now surgically removing the tumor in one lobe and radiofrequency ablation of other tumors in the surgery period time.


Objectives and subjects: A retrospective and prospective study conducted between 2020 and 2022, 09 patients with HCC with at least 2 tumors in different lobes underwent intraoperative radiofrequency ablation (IORFA) and followed-up for 3 months at Bach Mai Hospital.


Results: All 09 patients with 28 tumors, the number tumors from 02 to 06, each patient underwent surgery to remove 01 large tumor and radiofrequency ablation in surgery for other tumors. All patients responded completely according to mRECIST criteria, no local recurrence, relapsed or died within the first 3 months.


Conclusion: Intraoperative radiofrequency ablation is a new effective method approach, help to expand the indications for radical treatment for patients with multifocal hepatocellular carcinoma.

Article Details

Keywords

Intraoperative radiofrequency ablation, hepatocellular carcinoma

References

1. Globocan 2020. Accessed September 8, 2022.
2. Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7(1):42-49. doi:10.1080/13651820410024067
3. Cheung TT, Ng KK, Chok KS, et al. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes. World J Gastroenterol. 2010;16(24):3056-3062. doi:10.3748/wjg.v16. i24.3056
4. Lee JY, Kim YH, Roh YH, et al. Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon’s view. Ann Surg Treat Res. 2016;90(3):147-156. doi:10.4174/astr.2016.90.3.147
5. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị ung thư biểu mô tế bào gan 2020.
6. Lencioni R. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. SEMINARS IN LIVER DISEASE. 2010;30(1):9.
7. Mittal S, Kramer JR, Omino R, et al. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018;16(2):252-259. doi:10.1016/j.cgh.2017.08.042
8. Đặng Trung Thành. Nghiên cứu giá trị cận lâm sàng trong tiên lượng và theo dõi hiệu quả điều trị ung thư gan nút mạch hóa chất kết hợp đốt sóng cao tần.
9. Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma: Heimbach et al. Hepatology. 2018;67(1):358-380. doi:10.1002/hep.29086